We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current INBS market cap is 6.67M. The company's latest EPS is USD -2.3153 and P/E is -0.20.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 483k | 906k | 917k | 908k | 805k |
| Operating Income | -3.08M | -2.53M | -1.99M | -2.95M | -2.81M |
| Net Income | -2.66M | -2.43M | -1.97M | -2.98M | -2.78M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 189k | 1.98M | 437k | 2M | 3.54M |
| Operating Income | -2.71M | -5.71M | -8.34M | -12.6M | -10.28M |
| Net Income | -3.14M | -7.04M | -8.31M | -10.63M | -10.16M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 10.36M | 8.7M | 8.83M | 17.04M | 13.78M |
| Total Liabilities | 6.67M | 7.46M | 5.67M | 6.04M | 5.6M |
| Total Equity | 3.69M | 1.24M | 3.15M | 11M | 8.18M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.48M | 21.86M | 12.35M | 10.36M | 13.78M |
| Total Liabilities | 7.69M | 6.85M | 5.81M | 6.67M | 5.6M |
| Total Equity | -5.22M | 15.01M | 6.55M | 3.69M | 8.18M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.38M | -1.31M | -4.18M | -6.63M | -9.57M |
| Investing | -694k | N/A | -56k | -54k | -221k |
| Financing | 1.44M | N/A | 3.79M | 14.56M | 14.56M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -499k | -11.3M | -3.36M | -7.38M | -9.57M |
| Investing | -14k | N/A | -880k | -694k | -221k |
| Financing | 734k | 23.4M | N/A | 1.44M | 14.56M |
| Market Cap | 6.67M |
| Price to Earnings Ratio | -0.20 |
| Price to Sales Ratio | 0.58 |
| Price to Cash Ratio | 0.33 |
| Price to Book Ratio | 0.25 |
| Dividend Yield | - |
| Shares Outstanding | 4.39M |
| Average Volume (1 week) | 283k |
| Average Volume (1 Month) | 122.75k |
| 52 Week Change | -74.87% |
| 52 Week High | 11.70 |
| 52 Week Low | 1.00 |
| Spread (Intraday) | 0.03 (1.95%) |
| Company Name | Intelligent Bio Solutions Inc |
| Address |
2055 limestone road wilmington, delaware 198085539 |
| Website | https://www.gbs.inc |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
